Vor Biopharma
VOR
VOR
52 hedge funds and large institutions have $67.6M invested in Vor Biopharma in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 54 → 52 (-2)
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
53% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 15
Holders
52
Holding in Top 10
1
Calls
$78K
Puts
$13K
Top Buyers
| 1 | +$18.8M | |
| 2 | +$707K | |
| 3 | +$222K | |
| 4 |
Morgan Stanley
New York
|
+$150K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$128K |
Top Sellers
| 1 | -$1.73M | |
| 2 | -$723K | |
| 3 | -$251K | |
| 4 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$214K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$88.2K |